Thymic Stromal Lymphopoietin Blocker

Thymic Stromal Lymphopoietin Blockers

Asthma

<section class="Section" data-sectioncode="34089-3"><a name="ID_365046a1-2902-4fb1-ac55-0f3a4e020909"></a><a name="section-9"></a><p></p><h1>11 DESCRIPTION </h1><p class="First">Tezepelumab-ekko, a thymic stromal lymphopoietin (TSLP) blocker, is a human monoclonal antibody immunoglobulin G2λ (IgG2λ) produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology. Tezepelumab-ekko has a molecular weight of approximately 147 kDa.</p><p>TEZSPIRE (tezepelumab-ekko) injection is a sterile, preservative-free, clear to opalescent, colorless to light yellow solution for subcutaneous injection supplied in a single-dose vial, single-dose pre-filled syringe or single‑dose pre‑filled pen.</p><p>Each single-dose vial, pre-filled syringe or pre‑filled pen delivers 1.91 mL containing 210 mg tezepelumab-ekko, glacial acetic acid (2.8 mg), L-proline (48 mg), polysorbate 80 (0.19 mg), sodium hydroxide, and water for injection. The pH is 5.2.</p></section>

TEZSPIRE

tezepelumab

tezepelumab-ekko

1.91 ML tezepelumab-ekko 110 MG/ML Injection

Tezspire

1.91 ML tezepelumab-ekko 110 MG/ML Injection [Tezspire]

1.91 ML tezepelumab-ekko 110 MG/ML Prefilled Syringe

1.91 ML tezepelumab-ekko 110 MG/ML Prefilled Syringe [Tezspire]

1.91 ML tezepelumab-ekko 110 MG/ML Auto-Injector

1.91 ML tezepelumab-ekko 110 MG/ML Auto-Injector [Tezspire]

Psoriasis (PsO)

Psoriatic Arthritis (PsA)

Ankylosing Spondylitis (AS)

Nonradiographic Axial Spondyloarthritis

Taltz

Juvenile Idiopathic Arthritis

Hidradenitis Suppurativa (HS)

Cosentyx

Siliq

Tremfya

Crohn's Disease (CD)

Ulcerative Colitis (UC)

Stelara

Skyrizi

Ilumya

Migraine

Cluster Headache

Migraine Prevention

Emgality

Qulipta

Acute Migraine

Ubrelvy

Nurtec ODT

Vyepti

Aimovig

Ajovy

Breast Cancer: HR+ (HER2-)

Verzenio

Ibrance

Kisqali

Atopic Dermatitis (Eczema)

Cibinqo

Eucrisa

Asthma (injectable)

Asthma OCS Dependent

Nasal Polyposis

Eosinophilic Esophagitis (EoE)

Prurigo Nodularis

Dupixent

Opzelura

Adbry

NSCLC ALK+ OR ROS1+ Disease

Lorbrena

Alecensa

Alunbrig

NSCLC cMET Mutation

Xalkori

Rheumatoid Arthritis (RA)

Xeljanz

Uveitis

Graft Versus Host Disease (GVHD)

Orencia

COVID-19 Treatment

Alopecia Areata

Olumiant

Multiple Sclerosis (MS)

Secondary Progressive Multiple Sclerosis

Zeposia

Rinvoq

Entyvio

Report Adverse Event

Cost and Affordibility

What is Severe Asthma

What is Tezspire

Doctor Discussion Guide

Safety Information

Enroll in Patient Savings Program

Tezspire Together Ongoing Support Resources

FAQs

Mechanism of Action

Efficacy and Clinical Data

Safety Profile

Dosing and Administration

Tezspire Together Enrollment Form

Tezpire Together Enrollment Form Guide

Billing and Coding Guide

Prior Authorization and Appeals Checklist

Getting Started with Tezspire

Patient Treatment Tracker

Coverage Authorization Appeals

Letter of Medical Necessity

Pharmacy List

Online Sample Form

Patient Cases

Coverage Authorization Request

Instructions for Use

Reimbursement Information